Alimera Sciences

Alimera Sciences is a biotechnology company that develops and commercializes eye treatments, primarily focusing on conditions like diabetic macular edema, a complication of diabetes that can lead to vision loss. They create specialized drug treatments delivered through injections into the eye, aiming to improve transparency and value for patients and healthcare providers. The company's approach involves innovative drug delivery systems to ensure effective, long-lasting treatment. Overall, Alimera Sciences works to help preserve or improve vision for patients with serious eye diseases, leveraging science and technology to address unmet medical needs.